FDA Approves Risperdal in Children

The FDA recently approved the use of the antipsychotic Risperdal in children and adolescents with bipolar disorder and schizophrenia. Our Mental Health Experts weigh in on the implications of this decision.

Featured

FDA Greenlights Risperdal for Kids and Teens
Christina Bruni writes, "The FDA-endorsed treatment comes not a moment too soon; particularly since psychiatrists have been using it off-label for years."
FDA Approves Antipsychotic for Bipolar Kids: What Does It Mean?
John McManamy states, "For the medical part of treatment, it's all about matching the symptom to the compound. It's not about waiting for the DSM or the FDA to catch up to clinical reality."
FDA Approves Risperdal for Children: A Medical Advance or a Marketing Game?
"Having all all their bases covered with respect to Risperdal will make it much easier to market, and perhaps even get future FDA approvals on Invega," writes G.J. Gregory

FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar Disorder in Children
Robin Cunningham writes, "It is important that the consequences of the decision be closely monitored on a long term basis."
FDA Approves Risperdal for Children and Adolescents - a Good Move?
"We need to see more medications approved for children and adolescents, but we also need to see that they're prescribed and used correctly and safely," writes Teri Robert
The FDA approves a powerful anti-psychotic for use in children (seriously?)
Deborah Gray writes, "Over the past few years, we've found that that sense of security that consumers have in the FDA's approval of a drug may be misplaced (Vioxx, anyone?)."